Hint mode is switched on Switch off
For swift navigation between sections

GSK PLC, 6.375% 9mar2039, GBP (FIGI BBG0000MW5B1, XS0350820931, WKN A0TSC8)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

International bonds, Guaranteed, Senior Unsecured

Issue | Borrower
Borrower
  • M
    ***  | ***
    ***
  • S&P
    ***  | ***
    ***
  • F
    ***  | ***
    ***
Status
Outstanding
Amount
700,000,000 GBP
Placement
***
Redemption (put/call option)
*** (-)
ACI
Country of risk
United Kingdom
Current coupon
***%
Price
Yield / Duration
Reports of guarantors / borrowers / offerers
Guarantor GSK PLC
Reporting IFRS
  • Placement amount
    700,000,000 GBP
  • Outstanding amount
    700,000,000 GBP
  • USD equivalent
    939,750,000 USD
  • Minimum Settlement Amount
    50,000 GBP
  • ISIN
    XS0350820931
  • Common Code
    035082093
  • CFI
    DTFUFB
  • FIGI
    BBG0000MW5B1
  • SEDOL
    B2Q3R94
  • Ticker
    GSK 6.375 03/09/39 EMTN

Try in 7-days Trial access

Free for company representative

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
  • Evaluate advanced analytical tools
Sign up

Why Cbonds?

  • 24 Years of Market Leadership
  • Trusted by clients across 90 countries for decades of reliable service
  • Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
  • Convenient platform for private investors for informed investment decisions
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Files

Final Terms

Bond program

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
No more than two exchanges can be selected for comparison at the same time
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issue information

Profile
GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and ...
GSK PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
Show more Hide
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
Volume
  • Placement amount
    700,000,000 GBP
  • Outstanding amount
    700,000,000 GBP
  • Outstanding face value amount
    700,000,000 GBP
  • USD equivalent
    939,750,000 USD
Face value
  • Minimum Settlement Amount
    50,000 GBP
  • Outstanding face value
    *** GBP
  • Increment
    *** GBP
  • Face value
    1,000 GBP
Listing
  • Listing

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot
Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement format
    Book building
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Use of proceeds
    General Corporate Purposes
  • Use of proceeds description
    Unless otherwise stated in the applicable Final Terms, the net proceeds from each issue of Notes will be used for the general purposes of the Group and such specific purposes as may be determined from time to time. If the net proceeds, in relation to a particular Tranche of Notes, will be used for anything other than making profit and/or hedging certain risks, this will be stated in the applicable Final Terms.
Participants
  • Bookrunner
    ***, ***, ***

Conversion and exchange

  • Conversion terms
    ***

Issue is included in calculation of indices

Cbonds United Kingdom Corporate GBP Duration Index
Cbonds United Kingdom Corporate GBP Index
Cbonds United Kingdom Corporate GBP Price Index
Cbonds United Kingdom Corporate GBP T-spread Index
Cbonds United Kingdom Corporate GBP YTM Index
Show more Hide

Latest issues

Show all

Similar issues

News

22/07/2026 GSK PLC: Jideytro approved in US for certain lung cancers
09/06/2026 Nuvalent Acquisition: GSK's Strategic Move in Cancer Treatment and Market Reaction
09/06/2026 GSK PLC: Dr Hal Barron – New Directorship
10/02/2026 GSK PLC (NYSE:GSK) Maintains Neutral Rating from Citigroup Amidst Positive Developments
11/12/2025 GSK PLC: Blujepa approved in US for gonorrhoea indication
All organization news

IFRS/US GAAP reports

2026
I q eng
II q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
Show more Hide
Authorization required
You need to request access

Identifiers

  • ISIN
    XS0350820931
  • Cbonds ID
    49231
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    035082093
  • CFI
    DTFUFB
  • FIGI
    BBG0000MW5B1
  • WKN
    A0TSC8
  • SEDOL
    B2Q3R94
  • Ticker
    GSK 6.375 03/09/39 EMTN
  • Type of security by CBR
    ***
Show more Hide

Ratings

Bond classification

  • Senior Unsecured
  • Coupon bonds
  • Bearer
  • Guaranteed
  • Non-complex financial instruments (MiFID)
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Holders

Registration is required to get access.